Mr. Terry Booth reports

AURORA GRANTS RESTRICTED SHARE UNITS AND OPTIONS

Aurora Cannabis Inc. has granted stock options and restricted share units to directors and officers of the company.

Options to purchase 1.9 million common shares were granted pursuant to the company's stock option plan, exercisable at a price of $2.76 per common share for a term of five years, of which 525,000 vest over 12 months and 1,375,000 vest over 36 months, in equal quarterly instalments.

In addition, subject to approval of the RSU plan by the Toronto Stock Exchange and ratification by disinterested shareholders at the annual and special general meeting of the company on Nov. 13, 2017, 2,007,110 RSUs were awarded, of which 525,000 vest over 12 months, 1,375,000 vest over 36 months, in equal quarterly instalments, and 107,110 vest immediately.

A description of the RSU plan and the awards made under such plan will be set out in the management information circular of the company, which will be mailed to shareholders and filed on SEDAR in connection with the AGM.

About Aurora Cannabis Inc.

Aurora's wholly owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The company operates a 55,200-square-foot, state-of-the-art production facility in Mountain View county, Alberta, known as Aurora Mountain, is currently constructing a second 800,000-square-foot production facility, known as Aurora Sky, at the Edmonton International Airport, and has acquired and is undertaking completion of a third 40,000-square-foot production facility in Pointe-Claire, Que., on Montreal's West Island.

In addition, the company holds approximately 9.6 per cent of the issued shares (12.9 per cent on a fully diluted basis) in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1 per cent. Furthermore, Aurora is the cornerstone investor with a 19.9-per-cent stake in Cann Group Ltd., the first Australian company licensed to conduct research on and cultivate medical cannabis.

We seek Safe Harbor.